EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Implementing physician‐led medication reviews for patients with diabetes and severe mental disorder: A randomized controlled trial

Johan Frederik Mebus Meyer Christensen iD, Signe Wegmann Düring iD, Gesche Jürgens iD

British Journal of Clinical Pharmacology · 2025

DOI: 10.1002/bcp.70062 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Johan Frederik Mebus Meyer Christensen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit for Clinical Psychopharmacology, Mental Health Service West, Copenhagen University Hospital-Psychiatry West Region Zealand, Slagelse, D…. Hauptthemen laut MEDLINE: Mental Disorders, Diabetes Mellitus, Practice Patterns, Physicians'. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Steno Diabetes Center Zealand, Region Zealand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Patients with severe mental disorder and diabetes may be exposed to inappropriate polypharmacy increasing the risk of side effects and drug interactions. Although medication reviews may facilitate short‐term deprescribing, they are not known to affect clinical outcomes. We investigated whether implementing physician‐led medication reviews through interdisciplinary dialogue can change prescription patterns and improve pharmacological efficacy and tolerability in psychiatric outpatients with diabetes.

Methods

Included in the study were 52 patients from an endocrinologist–psychiatrist outpatient clinic in Slagelse Region, Zealand, Denmark. Patients were allocated to an intervention group, where patients' pharmacological treatment was discussed at an interdisciplinary treatment conference based on a medication review conducted by a specialist in clinical pharmacology or a control group receiving standard care. All patients underwent psychometric testing, side effect screening, clinical interviews, and had drug regimens and biochemical test results extracted from the electronic health records at baseline and at 6 months follow up.

Results

The trial was completed by 48 patients. Average time to follow up was 7 months (range 5–11 months). The intervention group had a median reduction of 1 drug (interquartile range [IQR] −4.00, 0.00) and 1 potentially inappropriate prescription (IQR –2.00, 0.00) compared to a median increase of 2 drugs (IQR 1.00, 3.00) and 2 potentially inappropriate prescriptions (IQR 0.00, 3.00) in the control group. The usage of both somatic and psychiatric drugs was reduced. We found no differences in clinical outcomes.

Conclusion

Deprescribing can be achieved without worsening psychiatric symptoms in psychiatric outpatients by implementing physician‐led medication reviews through interdisciplinary dialogue. This study was registered on ClinicalTrials.gov : NCT (05243160).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mental DisordersDiabetes MellitusPractice Patterns, Physicians'HumansFemaleMaleMiddle AgedPolypharmacyDenmarkAdultAgedInappropriate PrescribingDeprescriptionsFollow-Up StudiesPatient Care Team

Stichwörter der Autor:innen

clinical pharmacologydeprescribingdrug reviewmedication reviewmedicines optimizationpsychotropic deprescribingpsychotropic polypharmacy

Autor:innen und Institutionen

  • Research Unit for Clinical Psychopharmacology, Mental Health Service West, Copenhagen University Hospital-Psychiatry West Region Zealand, Slagelse, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Psychiatric Research Unit, Copenhagen University Hospital-Psychiatry Region Zealand, Slagelse, Denmark.
  • Clinical Pharmacology Unit, Zealand University Hospital Roskilde, Roskilde, Denmark.

ORCID-Profile: Johan Frederik Mebus Meyer Christensen, Signe Wegmann Düring, Gesche Jürgens

Förderung

  • Steno Diabetes Center Zealand
  • Region Zealand

Zitieren

APA

Christensen, J. F. M. M., Düring, S. W., & Jürgens, G. (2025). Implementing physician‐led medication reviews for patients with diabetes and severe mental disorder: A randomized controlled trial. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70062

Vancouver

Christensen JFMM, Düring SW, Jürgens G. Implementing physician‐led medication reviews for patients with diabetes and severe mental disorder: A randomized controlled trial. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70062

BibTeX
@article{Christensen2025,
  author = {Christensen, Johan Frederik Mebus Meyer and Düring, Signe Wegmann and Jürgens, Gesche},
  title = {Implementing physician‐led medication reviews for patients with diabetes and severe mental disorder: A randomized controlled trial},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1002/bcp.70062}
}
Kostenlos starten →